
A recent analysis showed a surge in prescription fills for hydroxychloroquine/chloroquine, likely due to off-label prescribing for coronavirus disease 2019.
A recent analysis showed a surge in prescription fills for hydroxychloroquine/chloroquine, likely due to off-label prescribing for coronavirus disease 2019.
Survey results reveal improvements and challenges in the workplace.
“Testing is coming, but getting there is a step-by-step process, and you need to work out the logistics.”
Pharmacies and pharmacists can help the rapid deployment of COVID-19 vaccines when available, NACDS said.
Can coronavirus-related stress cause shingles?
Apotex Corp is voluntarily recalling all lots of metformin hydrochloride extended-release tablets, USP 500 mg, within expiry to retail level.
Months after FDA said it was investigating the carcinogenic ingredient NDMA in metformin products, the agency’s testing has found elevated levels of NDMA in extended release metformin, but not in the immediate release formulation.
In a new consensus paper, experts emphasized that high doses of vitamin D supplementation have no current benefit in the prevention or treatment of COVID-19.
In part 2 of our interview, Mike Johnston, founder and chief executive officer of the National Pharmacy Technician Association (NPTA), discussed the results of their recent survey, which found that many pharmacists and pharmacy technicians feel unsafe from COVID-19 at their workplaces.
Supplementation during pregnancy can have potential positive health outcomes for offspring.
A new guidance from the US Department of Health & Human Services (HHS) paves the way for pharmacists nationwide to administer coronavirus disease 2019 (COVID-19) tests.
Mike Johnston, founder and chief executive officer of the National Pharmacy Technician Association (NPTA), joined Drug Topics® to discuss their recent survey that pinpointed where pharmacists are feeling most unprotected during the pandemic.
Community pharmacies are ideally positioned to support reopening efforts and recovery plans amid the coronavirus disease 2019 pandemic.
"I have to admit that in all 39 years of my career as a community pharmacist, I have never seen a drug that was the center of such intense political discussion."
Here's a roundup of the latest coronavirus-related news.
Heart disease is so common among Americans that it claims 1 life every 37 seconds.
Pharmacists are often the most accessible health care professionals, which is why a lack of access to pharmacies can have a detrimental effect on patients, especially those with chronic conditions.
Thank you to pharmacy staff on the front lines.
On Tuesday, California Governor Gavin Newsom granted California pharmacists the ability to order and administer coronavirus disease 2019 (COVID-19) tests.
A presentation from the 2020 PQA Annual Meeting discussed the emerging focus on social determinants of health within the industry and how pharmacists can address the issue.
Purdue University College of Pharmacy in West Lafayette, Indiana, helped its students graduate in record time this spring.
Nearly 94% of survey respondents agreed that provider status is important for the future of pharmacy.
Officials with the FDA granted Emergency Use Authorization (EUA) to the first diagnostic test that will allow at-home collection of saliva samples for coronavirus disease 2019 (COVID-19) testing.
The letter to congressional leaders warned that without reform, vulnerable populations could lose access to pharmacies, which are the first point-of-care for many.
The FDA recently added famotidine to its list of drug shortages.